ABI
AFFX

Adamant Biomedical Investments’s Affymetrix Inc AFFX Stock Holding History

Adamant Biomedical Investments’s Portfolio AFFX Stock Details AFFX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$494K Sell
50,000
-50,000
-50% -$437K 0.12% 93
2014
Q3 		$798K Buy
+100,000
New +$857K 0.2% 82

Other funds holding AFFX

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Adamant Biomedical Investments's AFFX Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Affymetrix Inc (AFFX) stake by 50% in Q4 2014, selling an estimated $437K and leaving 50,000 shares worth $494K. The position accounts for 0.12% of the portfolio, ranked #93.

Adamant Biomedical Investments first reported a position in AFFX in Q3 2014 and has held it in 2 quarters since. The position peaked at $798K in Q3 2014. 174 funds tracked by Wall St. Rank hold AFFX as of Q4 2014.

  • Adamant Biomedical Investments held 50,000 shares of Affymetrix Inc worth $494K as of Q4 2014.
  • Adamant Biomedical Investments sold 50,000 Affymetrix Inc shares in Q4 2014, an estimated $437K.
  • Affymetrix Inc made up 0.12% of Adamant Biomedical Investments's portfolio in Q4 2014, its #93 holding.
  • Adamant Biomedical Investments first reported a position in Affymetrix Inc in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Affymetrix Inc position peaked at $798K in Q3 2014.
  • 174 funds tracked by Wall St. Rank held Affymetrix Inc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.